IMI European Lead Factory — democratizing access to high-throughput screening

Philip S. Jones, Sylviane Boucharens,Stuart P. McElroy, Angus Morrison,Saman Honarnejad, Stan van Boeckel, Helma van den Hurk, Daniel Basting, Jörg Hüser, Stefan Jaroch,Eckhard Ottow, Jorg Benningshof,Rutger H. A. Folmer, Frank Leemhuis, Patricia M. Kramer-Verhulst, Vera J. M. Nies,Kristina M. Orrling, Ton Rijnders,Claudia Pfander,Ola Engkvist, Garry Pairaudeau,Peter B. Simpson,Jean-Yves Ortholand,Didier Roche, Alexander Dömling, Sven M. Kühnert, Peter W. M. Roevens,Herman van Vlijmen, Eva J. A. van Wanrooij, Christophe Verbruggen,Peter Nussbaumer,Huib Ovaa,Mario van der Stelt, Klaus Baek Simonsen, Lena Tagmose,Herbert Waldmann, James Duffy,Dirk Finsinger, Mirek Jurzak,Nicola A. Burgess-Brown,Wen H. Lee,Floris P. J. T. Rutjes, Hubert Haag, Christopher Kallus, Hartmut Mors,Thierry Dorval, Brigitte Lesur, Fernando Ramon Olayo, Daniel Hamza, Geraint Jones, Christopher Pearce, Alexander Piechot,Dimitrios Tzalis,Mads H. Clausen,Jeremy Davis, Daphné Derouane, Céline Vermeiren,Markus Kaiser, Robert A. Stockman,Denise V. Barrault,Andrew D. Pannifer,Jason R. Swedlow,Adam S. Nelson,Romano V. A. Orru, Eelco Ruijter, Steven P. van Helden, Volkhart M. Li, Ton Vries,Jon S. B. de Vlieger

NATURE REVIEWS DRUG DISCOVERY(2021)

引用 0|浏览25
暂无评分
摘要
The European Lead Factory combines assets and experience from major pharma with innovation and agility of academia and SMEs in a collaborative platform to expand access to high-throughput screening. With many successes heading towards the clinic, the organization is broadening its approach to screening and partnering.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要